Procurement of recombinant activin a protein, CF reagent used in the generation of retinal pigment epithelial cells from induced pluripotent stem cells.
Ended Awarded
- Contract number
- 75N98B21F00001
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,500
Award facts
- Contract value 100% obligated
- $24,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
About this award
The National Eye Institute (NEI), a civilian agency within the National Institutes of Health, awarded a $24.5K firm fixed-price BPA call contract to Research and Diagnostic Systems, Inc. (R&D Systems) on February 18, 2021, with an ultimate completion date of March 18, 2021. The procurement was for recombinant activin A protein, a critical flow cytometry reagent utilized in generating retinal pigment epithelial cells from induced pluripotent stem cells. This procurement was made without a set-aside designation, indicating open competition, and was performed under R&D Systems' existing Blanket Purchase Agreement with the NIH's Office of Logistics and Acquisition Operations. The place of performance was Minneapolis, Minnesota, where R&D Systems is headquartered.
R&D Systems, a subsidiary of Bio-Techne Corporation, is a specialized manufacturer of biological research materials and high-quality reagents serving federal agencies throughout the NIH ecosystem. The company has established itself as a critical supplier of recombinant human proteins, cytokines, antibodies, and specialized research reagents across multiple NIH institutes and agencies. This particular procurement directly supports the NEI's mission in vision research and represents a typical task order fulfillment under the company's comprehensive $10M BPA, which enables flexible sourcing of biological materials and laboratory supplies for biomedical research through September 30, 2025.
Quick answers
Who was awarded contract 75N98B21F00001?
75N98B21F00001 was awarded to Research And Diagnostic Systems, Inc. by National Eye Institute (National Institutes of Health) on February 18, 2021.
How much is contract 75N98B21F00001 worth?
The government has obligated $24,500 on 75N98B21F00001.
Is contract 75N98B21F00001 an order under another contract?
Yes. 75N98B21F00001 is a BPA call under HHSN263201600021B, a blanket purchase agreement.
Was contract 75N98B21F00001 competed?
The extent of competition for 75N98B21F00001 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award